We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Hydroxylapatite Soft-Tissue Filler Kindles an Immune Response

By HospiMedica International staff writers
Posted on 15 Oct 2008
Calcium hydroxylapatite (CaHA), a stable soft-tissue filler used for the treatment of facial wrinkles, stimulates an immune response with lymphocytic infiltration and foreign body giant cell formation but with no evidence of new collagen formation, claims a new study.

Researchers from the Mangat-Kuy Plastic Surgery Centers (Cincinnati, OH, USA) conducted a prospective case series and histological analysis of eight patients who were each injected subdermally with 0.1 mL of calcium hydroxylapatite in the superior postauricular sulcus; two patients were lost to follow-up. More...
Histological evaluation at 1, 6, or 18 months after injection showed that the calcium hydroxylapatite particles were surrounded by a lymphocytic infiltrate with multiple foreign body giant cells. The investigators found no evidence of new collagen formation, migration, or heterotopic bone growth. The study was published in the September/October 2008 issue of the Archives of Facial Plastic Surgery.

"Calcium hydroxylapatite possesses many of the characteristics of the ideal filler,” said co-author Allison Holzapfel, M.D. "The material is noncarcinogenic, nontoxic, easy to work with, malleable, relatively long-lasting, and somewhat removable. However, the material does cause an immunologic response, which most likely contributes to its variable resorption rate.”

Seventy percent of bone is made up of the inorganic mineral CaHA. Carbonated-calcium deficient hydroxylapatite is the main mineral of which dental enamel and dentin are comprised. Hydroxyapatite crystals are also found in the small calcifications (within the pineal gland and other structures) known as corpora arenacea or 'brain sand'. CaHA is used in many medical applications, such as dental ridge augmentation and tissue marking, as a filler material to replace amputated bone, as a coating to promote bone ingrowth into prosthetic implants, and in facial and plastic reconstructive surgery.

Related Links:
Mangat-Kuy Plastic Surgery Centers



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.